From CSRxP <[email protected]>
Subject CSRxP Statement on the Passing of David Mitchell
Date January 5, 2026 10:35 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Founder and President of Patients for Affordable Drugs Was a Tireless and
Effective Advocate for Patients









CSRxP STATEMENT ON THE PASSING OF DAVID MITCHELL

Founder and President of Patients for Affordable Drugs Was a Tireless and
Effective Advocate for Patients



Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released
the following statement Monday on the passing of Patients for Affordable Drugs
(P4AD) founder and immediate past president David Mitchell, following a 15-year
battle with multiple myeloma, a rare blood cancer.



“David Mitchell was a tireless champion for patients too often forced to
confront egregious prescription drug prices in order to manage a serious
illness and get the care they need,” said CSRxP executive director Lauren
Aronson. “As a patient who lived this experience while managing an uncurable
cancer, Mitchell’s advocacy carried tremendous weight and lent moral clarity to
the urgency to lower prescription drug prices for patients in the United
States. Mitchell, and the organization he established, played a critical role
in elevating prescription drug prices as essential to the national debate about
the affordability of health care, and achieving positive progress on reform. He
will be sorely missed.”



###

































Copyright © 2019 Campaign for Sustainable Rx Pricing
Our address is 1341 G St NW, #1100, Washington, DC xxxxxx


This email was sent to [email protected]. To unsubscribe please click
here.
<[link removed]>
Screenshot of the email generated on import

Message Analysis

  • Sender: n/a
  • Political Party: n/a
  • Country: n/a
  • State/Locality: n/a
  • Office: n/a
  • Email Providers:
    • Iterable